Narrative review / 2015
The National Lipid Association provided clinical recommendations on lifestyle therapies and patient-centered management of dyslipidemia.
An expert panel convened by the National Lipid Association developed recommendations for patient-centered management of dyslipidemia, guided by the principle that lowering atherogenic cholesterol reduces atherosclerotic cardiovascular disease risk. This document (Part 2) focuses on lifestyle therapies, management in special populations (such as youth, women, older patients, specific ethnic groups, and those with HIV or rheumatoid arthritis), and strategies to enhance adherence through team-based collaborative care.
- Study type
- Clinical practice guideline / expert consensus
- Who was studied
- Patients with dyslipidemia, including special populations
- What was measured
- Management of dyslipidemia, lifestyle therapies, cardiovascular risk reduction
THE PAPER
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA, NLA Expert Panel. J Clin Lipidol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.